Concepedia

Vanessa A. Fabrizio

VA

11

Publications

502

Citations

11

H-Index

2020

Active since

Affiliations

Memorial Sloan Kettering Cancer Center(Current)

Cornell University

Emory University

Medical College of Wisconsin

Cincinnati Children's Hospital Medical Center

Vanessa A. Fabrizio is an author at Memorial Sloan Kettering Cancer Center specializing in medicine, cell transplantation, and hematology.

ORCID

Top concepts

Publications per year

2020–2025

11

Publications

11

Optimal fludarabine lymphodepletion is associated with improved outcomes after CAR T-cell therapy

Vanessa A. Fabrizio, Jaap Jan Boelens, Audrey Mauguen et al. · Blood Advances · 2021 · 103 citations · Full text

, , +19

Tisagenlecleucel outcomes in relapsed/refractory extramedullary ALL: a Pediatric Real World CAR Consortium Report

Vanessa A. Fabrizio, Christine L. Phillips, Adam Lane et al. · Blood Advances · 2021 · 74 citations · Full text

, , +18

Outcomes After Nonresponse and Relapse Post-Tisagenlecleucel in Children, Adolescents, and Young Adults With B-Cell Acute Lymphoblastic Leukemia

Liora M. Schultz, Anne Eaton, Christina Baggott et al. · Journal of Clinical Oncology · 2022 · 71 citations · Full text

Real-world use of tisagenlecleucel in infant acute lymphoblastic leukemia

Amy Moskop, Lauren Pommert, Christina Baggott et al. · Blood Advances · 2022 · 61 citations · Full text

, , +20

Higher doses of tisagenlecleucel are associated with improved outcomes: a report from the pediatric real-world CAR consortium

Heather E. Stefanski, Anne Eaton, Christina Baggott et al. · Blood Advances · 2022 · 50 citations · Full text

Rows per page

1–5 of 11